Naomi Hunder is Chief Medical Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 54,427 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on May 02, 2022, when has been sold 43,177 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.4K
0% 3M change
0% 12M change
Total Value Held $0

Naomi Hunder Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2022
BUY
Grant, award, or other acquisition
-
43,177 Added 44.24%
54,427 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
11,250 Added 50.0%
11,250 Common Stock
NH

Naomi Hunder

Chief Medical Officer
Seattle, WA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX